期刊文献+

血管内皮细胞生长因子反义寡核苷酸联合低分子肝素治疗小鼠Lewis肺癌的研究 被引量:1

The effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer
原文传递
导出
摘要 目的探讨血管内皮细胞生长因子(VEGF)反义寡核苷酸和低分子肝素法安明单用或联用对小鼠Lewis肺癌生长、转移的抑制作用。方法复制小鼠Lewis肺癌模型40只,随机分为对照组、VEGF反义寡核苷酸(ASODN)组、VEGF错义寡核苷酸(MSODN)组、低分子肝素(LMWH)组及联合治疗组,每组8只,分别给予生理盐水、VEGF-ASODN、VEGF-MSODN、法安明及VEGF-ASODN+法安明皮下注射,隔日1次,共15次。检测皮下移植瘤变化和肺转移率;应用免疫组织化学的方法检测肿瘤组织微血管密度(MVD);应用Western印迹的方法检查肿瘤组织VEGF蛋白表达。结果ASODN、LMWH和联合治疗组的抑瘤率分别为47·34%、27·31%和59·03%;肺转移率分别为37·5%、37·5%和25%;MVD和VEGF蛋白表达降低;与对照组和MSODN组相比,抑瘤率和MVD差异均有统计学意义(P<0·05)。结论VEGF-ASODN和法安明具有下调VEGF表达,抗血管生成作用;二者联合有协同抗肿瘤作用。 Objective To investigate the inhibitory effect of vascular endothelial growth factor (VEGF) anfisense oligonucleofides or/and dalteparin sodium(fragmin) on tumor growth and metastasis of mice Lewis lung cancer. Methods 40 mice with Lewis lung cancer were randomizedly divided into five groups: control group, VEGF antisense oligonucleotides (ASODN)group, VEGF mismatch sense oligonucleotides(MSODN) group, low molecular weight hepsrin (LMWH)group, and combined group. Sodium chloride, VEGF-ASODN, VEGF -MSODN, fragmin, and VEGF-ASODN plus fragmin were given respectively (once every two days, 15 times altogether). The volume and weight of subcutaneous tumors were measured, and the rates of lung metastasis were detected by HE staining. The microvessel density (MVD) in tumor mass were measured by imuunohistochemistry staining. VEGF protein level in tumor tissue were detected by Western blot assay. Results After treatment , the tumor growth inhibitory rates were 47. 34%, 27. 31% and 59. 03%, and the rates of lung metastasis were 37. 5% , 37. 5% and 25% in ASODN , LMWH , and the combined group , respectively. Tumor MVD and VEGF protein expression of the above three groups were lower than those of the control group. There was a significant difference in regard to the tumor growth inhibitory rates and MVD between the above three treated groups and the control group as well as the MSODN group ( P 〈 0. 05 ). Conclusions VEGF-ASODN and fragmin may down-regnlate VEGF gene expression and inhibit angiogenesis, Combined use of fragmin can enhance anti- tumor effect of VEGF-ASODN.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第11期749-752,共4页 National Medical Journal of China
关键词 内皮 血管 内皮生长因子 肝素 低分子量 肺肿瘤 Endothelium, Endotheli vascular growth factor Heparin, low-molecular-weight lung neoplasma
  • 相关文献

参考文献13

  • 1Zhang QX,Magovern CJ,Mack CA,et al.Vascular endothelial growth factor is the major angiogenic factor in omentum:mechanism of the omentum-mediated angiogenesis.J Surg Res,1997,67:147-154. 被引量:1
  • 2Toim M,Matsumoto T,Bando H.Vascular endothelial growth factor:its prognostic,predictive,and therapeutic implications.Lancet Oncol,2001,2:667-673. 被引量:1
  • 3Kabbinavar F,Hurwitz HI,Fehrenbacher L,et al.Phase Ⅱ,randomized trial comparing bevacizumab plus fluorouracil(FU)/leucovorin(LV)with FU/LV alone in patients with metastatic colorectal cancer.J Clin Oncol,2003,21:60-65. 被引量:1
  • 4Kuenen BC,Rosen L,Smit EF,et al.Dose-Finding and Pharmascokinetic study of cisplatin,gemcitabine,and SU5416 in patients with solid tumors.J Chin Oncol,2002,20:1657-1667. 被引量:1
  • 5Mousa SA.Low-molecular-weight heparins in thrombosis and cancer:emerging links.Cardiovasc Drug Rev,2004,22:121-134. 被引量:1
  • 6Bobek V,Kovarik J.Antitumor and antimetastatic effect of warfarin and heparins.Biomed Pharmacother,2004,58:213-219. 被引量:1
  • 7Kakkar AK.Thrombosis and cancer.Hematol J,2004,5suppl:S20-23. 被引量:1
  • 8Li XM,Tang ZY,Zhou G,et al.Significant of vascular endothelial growth factor mRNA expression in invasion and metatasis of hepatocelluar carcinoma.J Exp Clin Cancer Res,1998,17:1-3. 被引量:1
  • 9徐婷,司徒锐.层粘连蛋白受体抗体及蛋白激酶C抑制剂体内阻断肿瘤转移的实验研究[J].中华病理学杂志,1998,27(5):344-347. 被引量:11
  • 10王辰,杜敏捷,曹大德,翁心植,吴小青,常青,王瑜.慢性肺原性心脏病急性发作期肺细小动脉血栓形成的病理观察[J].中华医学杂志,1997,77(2):123-125. 被引量:498

二级参考文献27

  • 1阮英茆,中华结核和呼吸杂志,1991年,14卷,5页 被引量:1
  • 2团体著者,中华病理学杂志,1990年,19卷,22页 被引量:1
  • 3程显声,中华结核和呼吸杂志,1984年,7卷,78页 被引量:1
  • 4司徒锐,癌症,1994年,13卷,119页 被引量:1
  • 5司徒锐,中华病理学杂志,1987年,16卷,195页 被引量:1
  • 6司徒锐,癌症,1986年,5卷,156页 被引量:1
  • 7Kasper HU, Ebert M, Malfertheiner P, et al. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density. Virchows Arch , 2001,438:116-120. 被引量:1
  • 8Bruns CJ, Harbison MT, Davis DW, et al. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res, 2000,6:1936-1948. 被引量:1
  • 9Bruns CJ, Solorzano CC, Harbison MT,et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res , 2000,60:2926-2935. 被引量:1
  • 10Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer, 2000,88:2239-2245. 被引量:1

共引文献535

同被引文献18

  • 1Roberto C, Femando P, Paolo T, et al .The heparins and cancer:review of clinical trials and biological properties. Vascular Med,2004,9:205-213. 被引量:1
  • 2Yu MK, Lee DY, Kim YS, et al. Antiangiogenic and Apoptotic Properties of a Novel Amphiphilic Folate-Heparin-Lithocholate Derivative Having Cellular Internality for Cancer Therapy. Pharma Res ,2007,24:705-714. 被引量:1
  • 3Abe R, Fujita Y, Yamagishi S, et al. Angiogenesis and metastasis inhibitors for the treatment of malignant melanoma. Mini Rev Med Chem, 2007, 7:649-661. 被引量:1
  • 4Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc Res Tech, 2003, 60:70-75 被引量:1
  • 5Pisano C, Aulicino C, Vesci L, et al. low-molecular-weight glycolsplit heparin as an antiangiogenic VEGF antagonist. Glycobiology, 2005, 15 : 1C- 6C. 被引量:1
  • 6Casu B, Guerrini M, Guglieri S, et al. Undersulfated and glycol-split heparins endowed with antiangiogenic activity. Med Chem,2004,47:838-848. 被引量:1
  • 7Norrby K. 2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis.Int J Exp Pathol,2000, 81 : 191-198. 被引量:1
  • 8Bjornsson TD, Schneider DE, Hecht AR, et al. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo dispositon. J Pharmacol Exp Ther, 1998, 245:804-808. 被引量:1
  • 9Thourani VH, Brar SS, Kennedy TP, et al. Nonanticoagulant heparin inhibits NF-kB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol,2000,278 : H2084-2093. 被引量:1
  • 10Kragh M, Binderup L, Vig Hjarnaa PJ, et al. Non-anti-coagulant heparin inhibits metastasis but not primary tumor growth. Oncol Rep,2005, 14: 99- 104. 被引量:1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部